Fig. 2From: Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center studyPresentation of patients who were treated with azathioprine and presented mild (< 2 ULN) or severe (> 2 ULN) hepatotoxicityBack to article page